Literature DB >> 26587442

Hypertensive Vasculopathy: An Exclusive Interview with Dr. Rhian M. Touyz, President of the International Society of Hypertension.

Jeong Bae Park1.   

Abstract

An exclusive interview by Prof. Jeong Bae Park conducted with Dr. Rhian M. Touyz in Seoul while she was visiting for the Korean Society of Hypertension, May 10, 2014. In this interview, Dr. Touyz explains and describes hypertensive vasculopathy.

Entities:  

Year:  2014        PMID： 26587442      PMCID： PMC4646129          DOI： 10.1159/000368811

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN： 2235-8668


  7 in total

Review 1.  Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.

Authors:  Dylan Burger; Rhian M Touyz
Journal:  J Am Soc Hypertens       Date:  2012-02-09

Review 2.  Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2012-03-23       Impact factor: 5.223

Review 3.  Reactive oxygen species and vascular biology: implications in human hypertension.

Authors:  Rhian M Touyz; Ana M Briones
Journal:  Hypertens Res       Date:  2010-10-28       Impact factor: 3.872

Review 4.  Angiotensin II and the vascular phenotype in hypertension.

Authors:  Carmine Savoia; Dylan Burger; Nobu Nishigaki; Augusto Montezano; Rhian M Touyz
Journal:  Expert Rev Mol Med       Date:  2011-03-30       Impact factor: 5.600

Review 5.  Structural abnormalities of small resistance arteries in essential hypertension.

Authors:  Damiano Rizzoni; Enrico Agabiti-Rosei
Journal:  Intern Emerg Med       Date:  2011-03-05       Impact factor: 3.397

Review 6.  Treatment of arterial remodeling in essential hypertension.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 7.  Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2013-06-06       Impact factor: 8.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.